Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use
Addictive Behaviors · 2024-09 · 156 · 108076
DOI: 10.1016/j.addbeh.2024.108076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addictive Behaviors, 2024-09. Verfasst von Shivani Mathur Gaiha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stanford REACH Lab, Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, CA, United States; Division of…. Hauptthemen laut MEDLINE: Marijuana Use. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Few studies examine the relationship between depression and use of specific tobacco and/or cannabis products among adolescents, young adults, and adults. We determined whether the odds of depression are greater among those who used specific tobacco and/or cannabis products and among co-users of tobacco and cannabis. METHOD: Cross-sectional online survey of a national convenience sample of 13-40-year-olds (N = 6,038). The survey included depression screening and past 30-day use of specific tobacco and cannabis products (cigarettes; e-cigarettes, vaped cannabis, little cigars, cigarillos, cigars, hookah, chewing tobacco, smoked cannabis, edible cannabis, blunts). Analyses correspond to the total sample, and 13-17-, 18-24-, and 25-40-year-olds. RESULTS: Among 5,281 individuals who responded to the depression screener and nine product use questions, 1,803 (34.1 %) reported co-use of at least one tobacco product and one cannabis product in the past 30 days. Past 30-day co-use was associated with higher likelihood of screening positive for depression compared to past 30-day use of tobacco-only (aOR = 1.32, 1.06-1.65; 0.006) or cannabis-only (aOR = 1.94, 1.28-2.94;
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stanford REACH Lab, Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, CA, United States; Division of Adolescent/Young Adult Medicine, Department of Pediatrics, Boston Chi…
- Department of Biomedical Data Science, Stanford University, CA, United States.
- Stanford REACH Lab, Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, CA, United States.
- Stanford REACH Lab, Division of Adolescent Medicine, Department of Pediatrics, Stanford University School of Medicine, CA, United States. Electronic address: Bonnie.HalpernFelsher@stanford.edu.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- National Institutes of Health
- National Science Foundation
- National Cancer Institute
Zitieren
APA
Gaiha, S. M., Wang, M., Baiocchi, M., & Halpern-Felsher, B. (2024). Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use. Addictive Behaviors, 156, 108076. https://doi.org/10.1016/j.addbeh.2024.108076
Vancouver
Gaiha SM, Wang M, Baiocchi M, Halpern-Felsher B. Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use. Addictive Behaviors. 2024;156:108076. doi:10.1016/j.addbeh.2024.108076
BibTeX
@article{Gaiha2024,
author = {Gaiha, Shivani Mathur and Wang, Maggie and Baiocchi, Mike and Halpern-Felsher, Bonnie},
title = {Depression screening outcomes among adolescents, young adults, and adults reporting past 30-day tobacco and cannabis use},
journal = {Addictive Behaviors},
year = {2024},
volume = {156},
pages = {108076},
doi = {10.1016/j.addbeh.2024.108076}
}
EUVIMED